MENU
ATHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Athira Pharma (ATHA) Ownership - Who owns Athira Pharma?
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more
Profile
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.06M
P/E Ratio
N/A
Total Cash
51.28M
Projected Growth
N/A
Total Debt
1.22M
Revenue
N/A
Risk (Beta)
2.84
Dividend Yield
N/A
Total Cash/Share
1.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATHA
Capitalization
14.1M
P/E Ratio
N/A
Risk (Beta)
2.84
Dividend Yield
N/A
Total Cash
51.3M
Total Cash/Share
1.31
Total Debt
1.22M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
44.8M
P/B Ratio
0.38
Cash Flow
N/A
Earnings
-2.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
4.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-95.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-88.52
Shares Held By Institutions
10.9M
Shares Outstanding - Current
39M
Total Liabilities
13.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-50.929
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com